Miragen Therapeutics, Inc., Viridian Therapeutics, Inc. - M&A Call Transcript
Good morning, and welcome to the miRagen Therapeutics Viridian acquisition webcast and conference call. (Operator Instructions) Please be advised that this audio presentation is being recorded.
Now I'd like to turn the call over to Jason Leverone, Chief Financial Officer of miRagen. Please proceed.
Thank you, operator, and good morning, everyone. Earlier today, we issued a press release that outlined our acquisition of Viridian Therapeutics. This release is available at miragen.com under the Investors tab.
Before we begin, I would like to remind everyone that statements made during this webcast relating to miRagen's expected future performance, future business prospects or future events or plans may include forward-looking statements, as defined under the Private Securities Litigation Reform Act of 1995. All such forward-looking statements are intended to be subject to the safe harbor protection provided by the Reform Act. Actual outcomes and results could differ
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
